Purchase Order 75N91024P00143
Award Date 1/24/24
Potential Completion Date 1/23/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10022, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Qlucore Inc., a foreign-owned, for-profit organization, by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services. The contract provides Qlucore's Qlucore Omics Explorer software, including four academic floating licenses (four concurrent users) and one next-generation sequencing (NGS) add-on floating license. The total ceiling value of the contract is $21,860.00, and it is a firm-fixed-price purchase order....
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $13,053 purchase order to Qiagen, LLC for service agreement work. Qiagen, a subsidiary of Qiagen N.V., will perform the services at its location in Bethesda, Maryland under the firm fixed price contract, which runs from September 1, 2023 through August 31, 2024. The award provides services to support the National Cancer Institute's research efforts as it works to prevent and cure cancer....
- This $467,900 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Qiagen, LLC. The contract calls for Qiagen to provide clinical interpretation services for genomic variants identified through large next-generation gene panels, whole exome sequencing, and whole transcriptome sequencing conducted as part of NCI's Clinical Oncologic Molecular Pathology...
- Qiagen, LLC was awarded a firm fixed price purchase order valued at approximately $723,300 by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. Under this contract, Qiagen will provide clinical interpretation of genomic variants from large next-generation panel testing, whole exome sequencing, and whole transcriptome sequencing. Performance will take place in Germantown, Maryland over a two year period concluding...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,400 firm fixed price purchase order to Thermo Electron North America LLC, doing business as Thermofisher Scientific, for software. The contract has a period of performance through January 21, 2025 with no set-aside designation utilized. Thermofisher Scientific will provide unspecified software to the National Cancer Institute to support its biomedical research mission under this...
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (DHHS). The $93,067.38 contract is for the procurement of one QIAGEN QIASYMPHONY SP System. This automated DNA/RNA extraction system will support the NCI's Cancer Center for Research (CCR) Laboratory of Pathology in processing tissue, blood, and other samples for cancer research and diagnostics. The contract...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed-price purchase order valued at $24,940 to Global Life Sciences Solutions USA LLC. The contract calls for the delivery of an imaging system and associated easy-to-use software for band analysis and quantification of protein and DNA gels. The products and services will support research activities across the Laboratory of Biochemistry and...
- This is a $85,445 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V., for CLC Genomics Workbench and CLC Genomics Server software licenses, modules, and maintenance services. The purchase supports the genomic analysis capabilities of the NIH Clinical Center's Department of Laboratory Medicine in its clinical research and testing programs. The award is not associated with a larger contract vehicle and does...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $21,700 purchase order to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. for laboratory testing services. The firm fixed price contract runs from January 5, 2024 through July 15, 2024 and will be performed in Boulder, Colorado. No additional details were provided regarding the scope of laboratory testing services requested under the solicitation. The award was...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a $33,012.50 firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V. This contract is for CLC BIO SOFTWARE FY24, with a completion date of December 31, 2024. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. The company has a history of...
Qlucore Inc. has been awarded a $23,600 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software. The contract has no set-aside designation and runs through January 23, 2025. Performance will take place in New York, New York to support the National Cancer Institute's research programs.
Generated 1/3/24, 9:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 1/2/24 |